Omecamtiv Mecarbil

N/A

Report date: 2026/02/13 20:01:31
NME

Base Information

Drug NameOmecamtiv Mecarbil
Drug Alias NameOmecamtiv mecarbilo美卡奥美坎替Omecamtivum mecarbilumCK-452AMG-423 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCardiac myosin stimulants
TargetsCardiac myosin
Therapy Area/IndicationsVentricular Dysfunction, LeftAngina PectorisMyocardial Ischemia +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[39] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAmgen IncCytokinetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytokinetics IncPpd Pharmaceutical Development (Beijing) Co LtdJi Xing Pharmaceuticals Ltd +[4] 
Inactive CompaniesAmgen IncAmgen Biotechnology Consultation (Shanghai) Co Ltd
Active IndicationsHeart Failure, SystolicHeart Failure
Inactive IndicationsVentricular Dysfunction, LeftAngina PectorisMyocardial Ischemia +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG